Found: 26
Select item for more details and to access through your institution.
Precision medicine: PI3K targeting in advanced breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Long-term outcome with targeted therapy in advanced/metastatic HER2-positive breast cancer: The Royal Marsden experience.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 401, doi. 10.1007/s10549-019-05406-6
- By:
- Publication type:
- Article
Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 317, doi. 10.1007/s10549-019-05405-7
- By:
- Publication type:
- Article
Time-to-surgery and overall survival after breast cancer diagnosis in a universal health system.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 441, doi. 10.1007/s10549-019-05404-8
- By:
- Publication type:
- Article
Differences in breast cancer outcomes amongst Black US-born and Caribbean-born immigrants.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 433, doi. 10.1007/s10549-019-05403-9
- By:
- Publication type:
- Article
Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 451, doi. 10.1007/s10549-019-05402-w
- By:
- Publication type:
- Article
Genomic landscape of ductal carcinoma in situ and association with progression.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 307, doi. 10.1007/s10549-019-05401-x
- By:
- Publication type:
- Article
Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11).
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 367, doi. 10.1007/s10549-019-05400-y
- By:
- Publication type:
- Article
Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 389, doi. 10.1007/s10549-019-05398-3
- By:
- Publication type:
- Article
Utilization, duration, and outcomes of neoadjuvant endocrine therapy in the United States.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 419, doi. 10.1007/s10549-019-05397-4
- By:
- Publication type:
- Article
Evaluation of phospho-histone H3 in Asian triple-negative breast cancer using multiplex immunofluorescence.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 295, doi. 10.1007/s10549-019-05396-5
- By:
- Publication type:
- Article
Phase II randomized controlled trial of hypnosis versus progressive muscle relaxation for body image after breast or gynecologic cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 357, doi. 10.1007/s10549-019-05395-6
- By:
- Publication type:
- Article
Rationale for evaluating breast cancers of Lynch syndrome patients for mismatch repair gene expression.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 469, doi. 10.1007/s10549-019-05394-7
- By:
- Publication type:
- Article
Effect of early adverse events resulting in ado-trastuzumab emtansine dose adjustments on survival outcomes of HER2+ advanced breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 473, doi. 10.1007/s10549-019-05393-8
- By:
- Publication type:
- Article
Randomized window of opportunity trial evaluating high-dose vitamin D in breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 347, doi. 10.1007/s10549-019-05392-9
- By:
- Publication type:
- Article
Allelic modification of breast cancer risk in women with an NBN mutation.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 427, doi. 10.1007/s10549-019-05391-w
- By:
- Publication type:
- Article
Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 283, doi. 10.1007/s10549-019-05390-x
- By:
- Publication type:
- Article
Letter regarding Sopik V et al. entitled "Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ".
- Published in:
- 2019
- By:
- Publication type:
- Letter
A multicentre, randomized pilot trial comparing vascular access strategies for early stage breast cancer patients receiving non-trastuzumab containing chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 337, doi. 10.1007/s10549-019-05388-5
- By:
- Publication type:
- Article
HER2 double-equivocal breast cancer in Chinese patients: a high concordance of HER2 status between different blocks from the same tumor.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 275, doi. 10.1007/s10549-019-05387-6
- By:
- Publication type:
- Article
Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 379, doi. 10.1007/s10549-019-05385-8
- By:
- Publication type:
- Article
A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 327, doi. 10.1007/s10549-019-05381-y
- By:
- Publication type:
- Article
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 263, doi. 10.1007/s10549-019-05380-z
- By:
- Publication type:
- Article
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 459, doi. 10.1007/s10549-019-05378-7
- By:
- Publication type:
- Article
Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 251, doi. 10.1007/s10549-019-05374-x
- By:
- Publication type:
- Article
Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 409, doi. 10.1007/s10549-019-05362-1
- By:
- Publication type:
- Article